Holdings
Ally Bridge Group (NY) LLC
As of Sep 30, 2026, Ally Bridge Group (NY) LLC reported 14 positions worth US$43.4M. Largest: Edgewise Therapeutics, Inc., ProMIS Neurosciences Inc. and Minerva Neurosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | 185K | US$7.53M | +102K | Sep 30, 2026 |
| ProMIS Neurosciences Inc. | 620K | US$6.73M | no change | Sep 30, 2026 |
| Minerva Neurosciences, Inc | 1.66M | US$5.55M | −520K | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 182K | US$5.3M | new | Sep 30, 2026 |
| Shattuck Labs, Inc. | 625K | US$4.26M | new | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. | 302K | US$4.15M | new | Sep 30, 2026 |
| AN2 Therapeutics, Inc. | 526K | US$2.8M | no change | Sep 30, 2026 |
| Eupraxia Pharmaceuticals, Inc. | 231K | US$2.1M | −21,053 | Sep 30, 2026 |
| Avalo Therapeutics, Inc. | 134K | US$2.06M | −15,571 | Sep 30, 2026 |
| Inventiva SA | 227K | US$839K | −408K | Sep 30, 2026 |